Suppr超能文献

双环中间体结构为深入了解人源 SIRT5(去琥珀酰化酶 5)的去琥珀酰化机制提供了线索。

The bicyclic intermediate structure provides insights into the desuccinylation mechanism of human sirtuin 5 (SIRT5).

机构信息

MacCHESS, Cornell High Energy Synchrotron Source, Cornell University, Ithaca, New York 14853, USA.

出版信息

J Biol Chem. 2012 Aug 17;287(34):28307-14. doi: 10.1074/jbc.M112.384511. Epub 2012 Jul 5.

Abstract

Sirtuins are pivotal regulators in various cellular processes, including transcription, DNA repair, genome stability, and energy metabolism. Their functions have been generally attributed to NAD-dependent deacetylase activity. However, human SIRT5 (sirtuin 5), which has been reported to exhibit little deacetylase activity, was recently identified as an NAD-dependent demalonylase and desuccinylase. Biochemical studies suggested that the mechanism of SIRT5-catalyzed demalonylation and desuccinylation is similar to that of deacetylation catalyzed by other sirtuins. Previously, we solved the crystal structure of a SIRT5-succinyl-lysine peptide-NAD complex. Here, we present two more structures: a binary complex of SIRT5 with an H3K9 succinyl peptide and a binary complex of SIRT5 with a bicyclic intermediate obtained by incubating SIRT5-H3K9 thiosuccinyl peptide co-crystals with NAD. To our knowledge, this represents the first bicyclic intermediate for a sirtuin-catalyzed deacylation reaction that has been captured in a crystal structure, thus providing unique insights into the reaction mechanism. The structural information should benefit the design of specific inhibitors for SIRT5 and help in exploring the therapeutic potential of targeting sirtuins for treating human diseases.

摘要

Sirtuins 是各种细胞过程中的关键调节因子,包括转录、DNA 修复、基因组稳定性和能量代谢。它们的功能通常归因于 NAD 依赖性脱乙酰酶活性。然而,最近被鉴定为 NAD 依赖性脱戊二酰基酶和脱琥珀酰基酶的人类 SIRT5(sirtuin 5)几乎没有脱乙酰酶活性。生化研究表明,SIRT5 催化脱戊二酰基和脱琥珀酰基的机制类似于其他 sirtuins 催化的脱乙酰化。此前,我们解决了 SIRT5-琥珀酰基-赖氨酸肽-NAD 复合物的晶体结构。在这里,我们呈现了另外两个结构:SIRT5 与 H3K9 琥珀酰化肽的二元复合物,以及 SIRT5 与通过用 NAD 孵育 SIRT5-H3K9 硫代琥珀酰肽共晶获得的双环中间体的二元复合物。据我们所知,这代表了第一个在晶体结构中捕获的 sirtuin 催化脱酰基反应的双环中间体,从而为反应机制提供了独特的见解。这些结构信息应该有助于设计针对 SIRT5 的特异性抑制剂,并有助于探索针对人类疾病的靶向 sirtuins 的治疗潜力。

相似文献

引用本文的文献

3
Inhibition of Sirtuin Deacylase Activity by Peroxynitrite.过氧亚硝酸盐抑制 Sirtuin 脱酰酶活性。
Biochemistry. 2024 Oct 1;63(19):2463-2476. doi: 10.1021/acs.biochem.4c00257. Epub 2024 Sep 10.
6
Structural Basis of Sirtuin 6-Catalyzed Nucleosome Deacetylation.Sirtuin 6 催化核小体去乙酰化的结构基础。
J Am Chem Soc. 2023 Mar 29;145(12):6811-6822. doi: 10.1021/jacs.2c13512. Epub 2023 Mar 17.

本文引用的文献

2
Thiosuccinyl peptides as Sirt5-specific inhibitors.硫代琥珀酰肽作为 Sirt5 的特异性抑制剂。
J Am Chem Soc. 2012 Feb 1;134(4):1922-5. doi: 10.1021/ja2090417. Epub 2012 Jan 20.
6
Neural sirtuin 6 (Sirt6) ablation attenuates somatic growth and causes obesity.神经 Sirtuin 6(Sirt6)缺失会减弱躯体生长并导致肥胖。
Proc Natl Acad Sci U S A. 2010 Dec 14;107(50):21790-4. doi: 10.1073/pnas.1016306107. Epub 2010 Nov 22.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验